CG1YYZZ
Planar Nuclear Medicine Imaging Endocrine System to None with None, Other Radionuclide Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | G Endocrine System |
| Operation | 1 Planar Nuclear Medicine Imaging |
| Body Part | Y Endocrine System |
| Approach | Y Other Radionuclide |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for single plane display of images developed from the capture of radioactive emissions
Procedure Overview
This family describes single-plane radioactive imaging of endocrine glands, most often a thyroid scan and sometimes a parathyroid or adrenal scan. A small amount of radioactive iodine or technetium pertechnetate is swallowed or injected, the gland absorbs it in proportion to how active its cells are, and a gamma camera held in one or two fixed positions captures flat, two-dimensional pictures of the uptake pattern.
Physicians use this scan to tell apart different causes of an overactive thyroid, such as Graves' disease versus a single toxic nodule, to characterize a thyroid nodule found on ultrasound, or to look for residual or recurrent thyroid cancer tissue after surgery. A parathyroid version, usually done with a sestamibi tracer, helps locate an overactive parathyroid gland before surgery. The scan is painless and usually completed within an hour of the tracer being given, though thyroid studies sometimes require the patient to return for delayed images.
Anatomy & Axis Detail
Endocrine System
Imaging across the endocrine system as a broader category is used when a clinical question, such as a suspected multi-gland syndrome or metastatic neuroendocrine disease, requires surveying more than one hormone-producing structure rather than isolating a single gland. Because endocrine glands vary widely in location, from the neck to the adrenal glands and beyond, this approach depends on radiotracers with affinity for shared receptor or uptake mechanisms across multiple endocrine tissues, such as somatostatin receptor or catecholamine-avid agents, so that abnormal foci anywhere in the distribution can be detected on a single set of planar images. This wider view is particularly relevant in syndromes where hyperfunctioning or neoplastic tissue may arise in more than one endocrine organ simultaneously, making a single-gland study insufficient.
Radionuclide: Other Radionuclide
Other Radionuclide is used when a nuclear medicine study employs a radioactive tracer that does not correspond to one of the specifically named isotope values in this axis, such as an uncommon or newer radiopharmaceutical. It functions as a catch-all so the procedure can still be coded precisely by section and root operation even when the exact tracer lacks its own dedicated code value.
Coding & Documentation
Coding from this family depends on documentation showing that only flat, single-position images were acquired, without a rotational SPECT component. The report should identify the tracer, the gland imaged, and the camera views obtained. A frequent mistake is applying this code when the department actually performed a combined uptake-and-scan visit; the uptake measurement and the imaging are distinct root operations and both must be captured if both were done. Another recurring error is defaulting to "planar" because that is the more familiar term, when the technologist's protocol notes actually describe a SPECT acquisition.
Commonly Confused With
The closest look-alike is Tomographic Nuclear Medicine Imaging of the endocrine system, which differs only in whether the camera rotated to produce 3D reconstructions; dual-phase parathyroid protocols in particular are frequently planar-only despite reports that use the word "tomographic" loosely. It is also confused with Nonimaging Nuclear Medicine Uptake, which measures gland function as a percentage or count rate and produces no picture at all.